查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1970720

內視鏡逆行性造影（ERCP）全球市場規模、佔有率、趨勢與成長分析報告（2026-2034年）

Global Endoscopic Retrograde Cholangiopancreatography Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 145 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計內視鏡逆行性造影(ERCP) 市場將從 2025 年的 29.9 億美元成長到 2034 年的 63.3 億美元，2026 年至 2034 年的複合年成長率為 8.69%。

隨著胃腸道診斷和治療性介入需求的不斷成長，內視鏡逆行性造影（ERCP）市場也蓬勃發展。內視鏡、支架和導管導引線技術的進步提高了ERCP手術的準確性、安全性和有效性。膽管和胰臟疾病發生率的上升，以及微創技術的進步，正推動ERCP在全球醫院和專科診所的廣泛應用。

未來的成長將由新一代成像系統、機器人技術和人工智慧驅動的診斷工具所主導。包括高清內視鏡和即時分析在內的視覺化技術的進步，正在提高檢出率和手術成功率。一次性ERCP器械因其能夠解決感染控制問題並提高操作效率，正變得越來越重要。此外，配備虛擬實境（VR）和模擬工具的培訓平台正在加速醫療專業人員的技能發展，並確保先進手術技術的廣泛應用。

醫療基礎設施投資的增加和專業醫療服務的全球化正在提振市場前景。設備製造商與研究機構之間的合作開發推動了創新進程，而以病人安全為中心的法規則確保了品質的持續改進。隨著技術創新重新定義微創介入治療，ERCP市場預計將作為先進胃腸道醫療保健的重要組成部分繼續擴張。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球內視鏡逆行性胰造影（ERCP）市場：依產品分類

  • 市場分析、洞察與預測
  • 內視鏡
  • 內視鏡治療設備
  • 視覺化系統
  • 能量裝置
  • 其他

第5章 全球內視鏡逆行性胰造影（ERCP）市場：依手術類型分類

  • 市場分析、洞察與預測
  • 膽道括約肌切開術
  • 膽道支架置入術
  • 膽管擴張
  • 胰管括約肌切開術
  • 胰管支架置入術
  • 胰管擴張

第6章 全球內視鏡逆行性胰造影（ERCP）市場：依最終用途分類

  • 市場分析、洞察與預測
  • 醫院
  • 門診部

第7章 全球內視鏡逆行性胰造影（ERCP）市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Olympus Corporation
    • Conmed Corporation
    • Boston Scientific Corporation
    • Medtronic PLC
    • Telemed System Inc
    • Ambu Inc
    • Fujifilm Holdings Corporation
    • Hobbs Medical Inc
    • Cook Group
    • Streis PLC
    • HOYA Group
    • Karl Storz SE & Co. KG
簡介目錄
Product Code: VMR112110586

The Endoscopic Retrograde Cholangiopancreatography Market size is expected to reach USD 6.33 Billion in 2034 from USD 2.99 Billion (2025) growing at a CAGR of 8.69% during 2026-2034.

The market for endoscopic retrograde cholangiopancreatography (ERCP) is advancing as gastrointestinal diagnostics and therapeutic interventions grow in demand. Technological innovations in endoscopes, stents, and guidewires are enhancing the precision, safety, and efficacy of ERCP procedures. The rising incidence of bile duct and pancreatic disorders, combined with advancements in minimally invasive techniques, is driving adoption in hospitals and specialty clinics worldwide.

Future growth will be shaped by next-generation imaging systems, robotics, and AI-powered diagnostic tools. Enhanced visualization through high-definition endoscopes and real-time analytics is improving detection rates and procedural success. Disposable ERCP devices are gaining importance, addressing infection control concerns and streamlining operational efficiency. Furthermore, training platforms with virtual reality and simulation tools are enhancing skill development among practitioners, ensuring wider adoption of advanced procedures.

The market outlook is reinforced by increasing investments in healthcare infrastructure and the globalization of specialized medical services. Collaborative partnerships between device manufacturers and research institutions are driving innovation pipelines, while regulatory emphasis on patient safety ensures continuous quality improvements. With technology redefining minimally invasive interventions, the ERCP market is positioned to expand as a critical component of advanced gastrointestinal care.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Endoscopes
  • Endotherapy Devices
  • Visualization Systems
  • Energy Devices
  • Others

By Procedure

  • Biliary Sphincterotomy
  • Biliary Stenting
  • Biliary Dilatation
  • Pancreatic Sphincterotomy
  • Pancreatic Duct Stenting
  • Pancreatic Duct Dilation

By End Use

  • Hospitals
  • Outpatient Facilities

COMPANIES PROFILED

  • Olympus Corporation, Conmed Corporation, Boston Scientific Corporation, Medtronic PLC, Telemed System Inc, Ambu Inc, Fujifilm Holdings Corporation, Hobbs Medical Inc, Cook Group, Streis PLC, HOYA Group, Karl Storz SE amp Co KG
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Endoscopes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Endotherapy Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Visualization Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Energy Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET: BY PROCEDURE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Procedure
  • 5.2. Biliary Sphincterotomy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Biliary Stenting Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Biliary Dilatation Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Pancreatic Sphincterotomy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Pancreatic Duct Stenting Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Pancreatic Duct Dilation Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET: BY END USE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End Use
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Outpatient Facilities Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product
    • 7.2.2 By Procedure
    • 7.2.3 By End Use
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product
    • 7.3.2 By Procedure
    • 7.3.3 By End Use
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product
    • 7.4.2 By Procedure
    • 7.4.3 By End Use
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product
    • 7.5.2 By Procedure
    • 7.5.3 By End Use
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product
    • 7.6.2 By Procedure
    • 7.6.3 By End Use
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Olympus Corporation
    • 9.2.2 Conmed Corporation
    • 9.2.3 Boston Scientific Corporation
    • 9.2.4 Medtronic PLC
    • 9.2.5 Telemed System Inc
    • 9.2.6 Ambu Inc
    • 9.2.7 Fujifilm Holdings Corporation
    • 9.2.8 Hobbs Medical Inc
    • 9.2.9 Cook Group
    • 9.2.10 Streis PLC
    • 9.2.11 HOYA Group
    • 9.2.12 Karl Storz SE & Co. KG